Screen LibraryTargeted therapies：mechanisms of resistance
Saved in:
| Corporate Authors: | |
|---|---|
| Group Author: | |
| Published: |
Humana Press,
|
| Publisher Address: | New York |
| Publication Dates: | c2011. |
| Literature type: | Book |
| Language: | English |
| Series: |
Molecular and translational medicine |
| Subjects: | |
| Online Access: |
http://dx.doi.org/10.1007/978-1-60761-478-4 |
| Carrier Form: | 1 online resource (xiv, 201 p.): ill. (some col.) |
| ISBN: |
9781607614784 (electronic bk.) 1607614782 (electronic bk.) |
| Index Number: | R96 |
| CLC: | R96 |
| Contents: |
Includes bibliographical references and index. Resistance to Targeted Therapies As a Result of Mutation(s) in the Target -- The Dynamics of the Cell Signaling Network; Implications for Targeted Therapies -- Cancer Signaling Network Analysis by Quantitative Mass Spectrometry -- Development and Implementation of Array Technologies for Proteomics: Clinical Implications and Applications -- Using Phosphoflow[tm] to Study Signaling Events of Subpopulations Resistant to Current Therapies -- Mathematical and Computational Models in Cancer -- Somatic Evolution of Acquired Drug Resistance in Cancer -- Interrogating Resistance to Targeted Therapy Using Genetically Engineered Mouse Models of Cancer -- microRNA: A Potential Therapy Able to Target Multiple Cancer Pathways -- Rational Combination of Targeted Agents to Overcome Cancer Cell Resistance. |